Advanced imaging uncovers that glioblastoma affects the skull and immune system, not just the brain.
Key Details
- 1Montefiore Einstein researchers found glioblastoma erodes skull bones and alters skull marrow immune makeup.
- 2CT imaging of patients showed similar skull erosions as seen in mouse models with glioblastoma.
- 3Single-cell RNA sequencing revealed a shift toward pro-inflammatory immune cells in the skull marrow.
- 4FDA-approved osteoporosis drugs halted skull erosion but made tumors more aggressive and impaired immunotherapy effects.
- 5Findings suggest glioblastoma should be seen as a systemic, not just local, disease.
Why It Matters
These findings highlight the need for radiologists to consider extracranial effects when imaging glioblastoma and suggest that traditional local-treatment approaches may overlook critical systemic interactions. Understanding these effects can influence both diagnostic imaging strategies and future treatment planning.
Source
EurekAlert
Related News
•EurekAlert
UVA's $4M NIH Grant Backs AI to Optimize Cardiac MRI Therapies
UVA secures $4 million NIH funding to develop GenStrain, an AI model using MRI data to personalize cardiac pacing therapies.
•EurekAlert
Machine Learning Models Predict Cancer Risk with Routine Health Data
Researchers developed machine learning models using routinely collected health data to predict individual risk for 20 common cancers, outperforming traditional methods for several cancer types.
•EurekAlert
Duke Receives $25M to Lead National Trustworthy AI Hub for Dementia and Aging
Duke University has launched a $25 million national center to make AI for aging and dementia clinically robust and trustworthy.